Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Carcinoma of bladder
CUI: C0699885
Disease: Carcinoma of bladder
309 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2008 2008
Laryngeal Diseases
CUI: C0023051
Disease: Laryngeal Diseases
7 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2008 2008
Malignant neoplasm of urinary bladder
316 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2008 2008
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.080 0.875 8 2009 2018
Adenoma of large intestine
CUI: C1302401
Disease: Adenoma of large intestine
213 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.760 0.857 7 2010 2019
Nasopharyngeal carcinoma
CUI: C2931822
Disease: Nasopharyngeal carcinoma
320 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.700 1.000 1 2010 2010
Malignant neoplasm of stomach
CUI: C0024623
Disease: Malignant neoplasm of stomach
615 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.030 0.667 3 2011 2017
Stomach Carcinoma
CUI: C0699791
Disease: Stomach Carcinoma
652 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.030 0.667 3 2011 2017
Differentiated Thyroid Gland Carcinoma
80 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1 2011 2011
Metastasis from malignant tumor of prostate
18 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2011 2011
Metastatic Prostate Carcinoma
CUI: C0936223
Disease: Metastatic Prostate Carcinoma
24 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2011 2011
Primary differentiated carcinoma of thyroid gland
41 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1 2011 2011
Malignant neoplasm of thyroid
CUI: C0007115
Disease: Malignant neoplasm of thyroid
103 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.050 1.000 5 2012 2017
Thyroid carcinoma
CUI: C0549473
Disease: Thyroid carcinoma
145 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.050 1.000 5 2012 2017
Thyroid Neoplasm
CUI: C0040136
Disease: Thyroid Neoplasm
135 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.050 1.000 5 2012 2017
Papillary thyroid carcinoma
CUI: C0238463
Disease: Papillary thyroid carcinoma
204 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.020 2 2012 2015
Alcohol or Other Drugs use
CUI: C0237123
Disease: Alcohol or Other Drugs use
21 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2012 2012
Diabetes Mellitus, Non-Insulin-Dependent
2672 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2012 2012
Intestinal Neoplasms
CUI: C0021841
Disease: Intestinal Neoplasms
2 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2012 2012
polyps
CUI: C0032584
Disease: polyps
18 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2014 2014
Endometrial Carcinoma
CUI: C0476089
Disease: Endometrial Carcinoma
326 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2016 2016
Secondary malignant neoplasm of lymph node
188 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2016 2016
Adenomatous Polyps
CUI: C0206677
Disease: Adenomatous Polyps
20 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2017 2017
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2017 2017
Carcinoma, Ovarian Epithelial
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
327 0.578 0.440 8 127401060 non coding transcript exon variant G/T snv 0.37 0.010 1.000 1 2017 2017